Nomura Holdings
XENE icon

Nomura Holdings’s Xenon Pharmaceuticals XENE Stock Holding History

Nomura Holdings’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.36M Sell
75,000
-75,000
-50% -$3.46M 0.01% 683
2025
Q4 		$6.72M Buy
+150,000
New +$6.3M 0.01% 683

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nomura Holdings's XENE Position: Q2 2023 in Review

Nomura Holdings sold out of Xenon Pharmaceuticals (XENE) in Q2 2023, closing a stake of 221,095 shares — an estimated $7.91M sold.

Nomura Holdings first reported a position in XENE in Q1 2023 and held it in 1 quarter. The position peaked at $7.91M in Q1 2023. 175 funds tracked by Wall St. Rank hold XENE as of Q2 2023.

  • Nomura Holdings reported no remaining Xenon Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Nomura Holdings sold 221,095 Xenon Pharmaceuticals shares in Q2 2023, an estimated $7.91M.
  • Nomura Holdings first reported a position in Xenon Pharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Nomura Holdings's Xenon Pharmaceuticals position peaked at $7.91M in Q1 2023.
  • 175 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2023.

Based on Nomura Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.